CIK: 0001687078
Total reported value
$1.3B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CGEM | Cullinan Therapeutics INC | Stock-Other | 41.43% | -0.67% | — | |
| 2 | ✓ | Stock-Other | 10.25% | — | — | ||
| 3 | 2662247D | Iteos Therapeutics INC | Stock-Other | 10.12% | — | — | |
| 4 | TCRRUSD | Tcr2 Therapeutics INC | Stock-Other | 9.35% | — | — | |
| 5 | RPTX | Repare Therapeutics INC | Stock-Other | 7.98% | — | -13.34% | |
| 6 | ✓ | MEI Pharma, Inc. | Stock-Other | 4.37% | — | — | |
| 7 | ✓ | Oncorus INC | Stock-Other | 4.16% | — | — | |
| 8 | TPB | Turning Point Brands, Inc. | Stock-Other | 3.20% | — | -12.80% | |
| 9 | GTHXEUR | G1 Therapeutics INC | Stock-Other | 2.80% | — | -34.84% | |
| 10 | EPZMEUR | Epizyme INC | Stock-Other | 2.55% | — | — | |
| 11 | ✓ | Merus N V | Stock-Other | 1.84% | — | — | |
| 12 | YMABUSD | Y-mabs Therapeutics INC | Stock-Other | 1.28% | — | — | |
| 13 | ✓ | Adc Therapeutics SA | Stock-Other | 0.67% | — | -59.60% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | Merus N V | -0.3% | — | Unchanged |
| 2 | ✓ | MEI Pharma, Inc. | -0.3% | — | Unchanged |
| 3 | ✓ | -1.1% | — | Unchanged | |
| 4 | YMABUSD | Y-mabs Therapeutics INC | -1.7% | — | Unchanged |
| 5 | GTHXEUR | G1 Therapeutics INC | -1.7% | -34.84% | Trim |
| 6 | EPZMEUR | Epizyme INC | -1.9% | — | Unchanged |
| 7 | ✓ | Adc Therapeutics SA | -2.4% | -59.60% | Trim |
| 8 | TPB | Turning Point Brands, Inc. | -3.4% | -12.80% | Trim |
| 9 | 2662247D | Iteos Therapeutics INC | -3.9% | — | Unchanged |
| 10 | RPTX | Repare Therapeutics INC | -6.4% | -13.34% | Trim |
| 11 | TCRRUSD | Tcr2 Therapeutics INC | -9% | — | Unchanged |
| 12 | ✓ | Oncorus INC | -9.3% | — | Unchanged |
| 13 | CGEM | Cullinan Therapeutics INC | — | NEW | New buy |
| 14 | AUTL | Autolus Therapeutics PLC | — | EXIT | Sold out |